Animal-Derived Surfactants Versus Past and Current Synthetic Surfactants: Current Status

Clinics in Perinatology

Volumn 34, Issue 1, 2007, Pages 145-177

  Moya, Fernando ^a,b,c   Maturana, Andrés ^d,e  

^a New Hanover Regional Medical Center   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c Discovery Laboratories Inc   (United States)

^d UNIVERSIDAD DEL DESARROLLO   (Chile)

^e UNIVERSIDAD DEL DESARROLLO   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

BERACTANT; CALFACTANT; DIPALMITOYLPHOSPHATIDYLCHOLINE; LUCINACTANT; LUSUPULTIDE; PALMITOYLOLEYLPHOSPHATIDYLGLYCEROL; PHOSPHATIDYLGLYCEROL; PORACTANT; PUMACTANT; STEROID; SURFACTANT; SURFACTANT PROTEIN B; SURFACTANT PROTEIN C; UNCLASSIFIED DRUG;

AIRWAY OBSTRUCTION; BRADYCARDIA; BRAIN HEMORRHAGE; BRAIN PERIVENTRICULAR LEUKOMALACIA; CLINICAL TRIAL; DRUG EFFECT; DRUG EFFICACY; DRUG USE; EVALUATION; FOLLOW UP; HUMAN; HYPOXIA; LEUKOMALACIA; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN; OUTCOME ASSESSMENT; OUTCOMES RESEARCH; OXYGEN DESATURATION; PNEUMOTHORAX; PRIORITY JOURNAL; REVIEW; RISK REDUCTION;

ANIMALS; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; PULMONARY SURFACTANTS; RESPIRATORY DISTRESS SYNDROME, NEWBORN;

EID: 33947522869     PISSN: 00955108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clp.2006.12.005     Document Type: Review

References (32)

1. Jobe A.H. Why surfactant works for respiratory distress syndrome. NeoReviews 7 2 (2006) 95-106
2. Yost CC, Soll RF. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome. Cochrane Database Syst Rev 2000;(2):CD001456.
3. Soll RF, Morley CJ. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev 2001;(2):CD000510.
4. Halliday H.L. Recent clinical trials of surfactant treatment for neonates. Biol Neonate 89 (2006) 323-329
5. Soll RF, Blanco F. Natural surfactant extract versus synthetic surfactant for neonatal respiratory distress syndrome. Cochrane Database Syst Rev 2001;(2):CD000144.
6. Horbar J.D., Wright L.L., Soll R.F., et al. A multicenter randomized trial comparing two surfactants for the treatment of neonatal respiratory distress syndrome. J Pediatr 123 (1993) 757-766
7. Sehgal S.S., Ewing C.K., Richards T., et al. Modified bovine surfactant (Survanta) versus a protein-free surfactant (Exosurf) in the treatment of respiratory distress syndrome in preterm infants: a pilot study. J Natl Med Assoc 86 (1994) 46-52
8. Vermont-Oxford Neonatal Network. A multicenter, randomized trial comparing synthetic surfactant with modified bovine surfactant extract in the treatment of neonatal respiratory distress syndrome. Pediatrics 97 (1996) 1-6
9. Modanlou H.D., Beharry K., Padilla G., et al. Comparative efficacy of Exosurf and Survanta surfactants on early clinical course of respiratory distress syndrome and complications of prematurity. J Perinatol 17 (1997) 455-460
10. da Costa D.E., Pai M.G.K., and Al Kusaiby S.M. Comparative trial of artificial and natural surfactants in the treatment of respiratory distress syndrome of prematurity: experiences in a developing county. Pediatr Pulmonol 27 (1999) 312-317
11. Hudak M.L., Farrell E.E., Rosenberg A.A., et al. A multicenter randomized, masked comparison trial of natural versus synthetic surfactant for the treatment of respiratory distress syndrome. J Pediatr 128 (1996) 396-406
12. Hudak M.L., Martin D.J., Egan E.A., et al. A multicenter randomized masked comparison trial of synthetic surfactant versus calf lung surfactant extract in the prevention of neonatal respiratory distress syndrome. Pediatrics 100 (1997) 39-50
13. Kukkonen A.K., Virtanen M., Järvenpää A.-L., et al. Randomized trial comparing natural and synthetic surfactant: increased infection rate after natural surfactant?. Acta Paediatr 89 (2000) 556-561
14. Ainsworth S.B., Beresford M.W., Milligan D.W.A., et al. Pumactant and poractant alfa for treatment of respiratory distress syndrome in neonates born at 25-29 weeks' gestation: a randomised trial. Lancet 355 (2000) 1387-1392
15. Jadad A.R., Moore R.A., Carroll D., et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials 17 (1996) 1-12
16. Moya F.R., Gadzinowski J., Bancalari E., et al. A multicenter, randomized, masked, comparison trial of lucinactant, colfosceril palmitate and beractant for the prevention of respiratory distress syndrome among very preterm infants. Pediatrics 115 (2005) 1018-1029
17. Hall S.B., Venkitaraman A.R., Whitsett J.A., et al. Importance of hydrophobic apoproteins as constituents of clinical exogenous surfactants. Am Rev Respir Dis 145 (1992) 24-30
18. Cummings J.J., Holm B.A., Hudak M.L., et al. A controlled clinical comparison of four different surfactant preparations in surfactant-deficient preterm lambs. Am Rev Respir Dis 145 (1992) 999-1004
19. Bloom B.T., Kattwinkel J., Hall R.T., et al. Comparison of Infasurf (calf lung surfactant extract) to Survanta (beractant) in the treatment and prevention of respiratory distress syndrome. Pediatrics 100 (1997) 31-38
20. Attar M.A., Becker M.A., Dechert R.E., et al. Immediate changes in lung compliance following natural surfactant administration in premature infants with respiratory distress syndrome: a controlled trial. J Perinatol 24 (2004) 626-630
21. Bloom B.T., and Clark R.H. Comparison of Infasurf (calfactant) and Survanta (beractant) in the prevention and treatment of respiratory distress syndrome. Pediatrics 116 (2005) 392-399
22. Baroutis G., Kaleyias J., Liarou T., et al. Comparison of three treatment regimens of natural surfactant preparations in neonatal respiratory distress syndrome. Eur J Pediatr 162 (2003) 476-480
23. Hammoud M., Al-Kazmi N., Alshemmiri M., et al. Randomized clinical trial comparing two natural surfactant preparations to treat respiratory distress syndrome. J Matern Fetal Neonatal Med 15 (2004) 167-175
24. Yalaz M., Arslanoglu S., Akisu M., et al. A comparison of efficacy between two natural exogenous surfactant preparations in premature infants with respiratory distress syndrome. Klin Pädiatr 216 (2004) 230-235
25. Speer C.P., Gefeller O., Groneck P., et al. Randomised clinical trial of two treatment regimens of natural surfactant preparations in neonatal respiratory distress syndrome. Arch Dis Child 72 (1995) F8-F13
26. Ramanathan R., Rasmussen M.R., Gerstmann D.R., et al. A randomized, multicenter masked comparison trial of poractant alfa (Curosurf) versus beractant (Survanta) in the treatment of respiratory distress syndrome in preterm infants. Am J Perinatol 21 3 (2004) 109-119
27. Malloy C.A., Nicoski P., and Muraskas J.K. A randomized trial comparing beractant and poractant treatment in neonatal respiratory distress syndrome. Acta Paediatr 94 (2005) 779-784
28. Murdoch E., and Kempley S.T. The effects of synthetic and natural surfactant on fluid balance in acute respiratory distress syndrome. Eur J Pediatr 159 (2000) 767-769
29. Cochrane C.G., and Revak S.D. Pulmonary surfactant protein B (SP-B): structure-function relationships. Science 254 (1991) 566-568
30. Revak S.D., Merritt T.A., Cochrane C.G., et al. Efficacy of synthetic peptide-containing surfactant in the treatment of respiratory distress syndrome in preterm infant rhesus monkeys. Pediatr Res 39 (1996) 715-724
31. Kinniry P., Pick J., Stephens S., et al. KL4-surfactant prevents hyperoxic and LPS-induced lung injury in mice. Pediatr Pulmonol 41 (2006) 916-928
32. Sinha S.K., Lacaze-Masmonteil T., Soler A.V., et al. A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome. Pediatrics 115 (2005) 1030-1038